Changes needed:
General
2007 Other Sites rules in effect until 12/31/2022 (extended from 2021)
Breast
Table 3 8500 row: these subtypes were added: Ductal carcinoma in situ, solid type/intraductal carcinoma, solid type 8230/2; Solid carcinoma/solid adenocarcinoma 8230/3
Table 3 8503 row: Tall cell carcinoma with reverse polarity 8509/3
Colon
Table 1 8140 row: Subtype added: High grade appendiceal mucinous neoplasm (HAMN)/Low grade appendiceal mucinous neoplasm 8480 (I don't think you need to do anything for this addition because 8480 is already there as Mucinous/colloid adenocarcinoma/carcinoma, but if you want to update the term you can?)
New H rule: see H5. Code low grade appendiceal mucinous neoplasm (LAMN) and high grade appendiceal mucinous neoplasm (HAMN) 8480/2 when:…
For M7 and M8- the time interval is changing for cases diagnosed 1/1/2022 and later. This applies to both rules. 24 to 36 months.
Head and Neck
Table 1
Non-keratinizing squamous cell carcinoma 8072 row deleted; 8072 moved to the subtype/variant column of the 8070 row
8070 row: These were added as subtypes: Squamous cell carcinoma, large cell, nonkeratinizing/Squamous cell carcinoma, nonkeratinizing, NOS 8072; Schneiderian carcinoma/cylindrical cell carcinoma 8121; Sarcomatoid squamous cell carcinoma/spindle cell squamous cell carcinoma (SC-SCC) 8074
Table 2
8070 row: These were added as subtypes: Lymphoepithelial carcinoma 8082 Undifferentiated carcinoma/Undifferentiated carcinoma with lymphoid stroma 8020
Table 4:
C024 Lingual tonsil removed from Table 4 and moved to Table 5
Table 5:
C024 Lingual tonsil added to Table 5
Table 10
Paired sites updated: Tonsil changed to "C098, C099"
Kidney
Table 1: Sarcoma row 8800: Spindle cell/sclerosing rhabdomyosarcoma 8912/3 moved to be indented under Rhabdomyosarcoma 8900/3 (error fix)
Table 1: Renal cell carcinoma row 8312: "Succinate dehydrogenase-deficient renal cell carcinoma (SDHS) 8311* (reportable beginning 1/1/2022)" added as a subtype/variant
For Kidney 8311, this histology should be excluded from M8 (single primary when single histology rule). See the new Note 2 until Rule M7.
Note 2: Abstract multiple primaries when you have any of the following combinations (all coded 8311):
• MiT family translocation renal cell carcinoma and Hereditary leiomyomatosis
• MiT family translocation renal cell carcinoma and Renal cell carcinoma-associated renal cell carcinoma
• MiT family translocation renal cell carcinoma and Succinate dehydrogenase-deficient renal cell carcinoma (SDHS)
• Hereditary leiomyomatosis and Succinate dehydrogenase-deficient renal cell carcinoma (SDHS)
• Renal cell carcinoma-associated renal cell carcinoma and Succinate dehydrogenase-deficient renal cell carcinoma (SDHS)
Malignant CNS
Table 3: 9540 row: Added as a subtype/variant: "Epithelioid malignant peripheral nerve sheath tumor 9542"
Changes needed: General 2007 Other Sites rules in effect until 12/31/2022 (extended from 2021)
Breast Table 3 8500 row: these subtypes were added: Ductal carcinoma in situ, solid type/intraductal carcinoma, solid type 8230/2; Solid carcinoma/solid adenocarcinoma 8230/3 Table 3 8503 row: Tall cell carcinoma with reverse polarity 8509/3
Colon Table 1 8140 row: Subtype added: High grade appendiceal mucinous neoplasm (HAMN)/Low grade appendiceal mucinous neoplasm 8480 (I don't think you need to do anything for this addition because 8480 is already there as Mucinous/colloid adenocarcinoma/carcinoma, but if you want to update the term you can?) New H rule: see H5. Code low grade appendiceal mucinous neoplasm (LAMN) and high grade appendiceal mucinous neoplasm (HAMN) 8480/2 when:… For M7 and M8- the time interval is changing for cases diagnosed 1/1/2022 and later. This applies to both rules. 24 to 36 months.
Head and Neck Table 1 Non-keratinizing squamous cell carcinoma 8072 row deleted; 8072 moved to the subtype/variant column of the 8070 row 8070 row: These were added as subtypes: Squamous cell carcinoma, large cell, nonkeratinizing/Squamous cell carcinoma, nonkeratinizing, NOS 8072; Schneiderian carcinoma/cylindrical cell carcinoma 8121; Sarcomatoid squamous cell carcinoma/spindle cell squamous cell carcinoma (SC-SCC) 8074 Table 2 8070 row: These were added as subtypes: Lymphoepithelial carcinoma 8082 Undifferentiated carcinoma/Undifferentiated carcinoma with lymphoid stroma 8020 Table 4: C024 Lingual tonsil removed from Table 4 and moved to Table 5 Table 5: C024 Lingual tonsil added to Table 5 Table 10 Paired sites updated: Tonsil changed to "C098, C099"
Kidney Table 1: Sarcoma row 8800: Spindle cell/sclerosing rhabdomyosarcoma 8912/3 moved to be indented under Rhabdomyosarcoma 8900/3 (error fix) Table 1: Renal cell carcinoma row 8312: "Succinate dehydrogenase-deficient renal cell carcinoma (SDHS) 8311* (reportable beginning 1/1/2022)" added as a subtype/variant
For Kidney 8311, this histology should be excluded from M8 (single primary when single histology rule). See the new Note 2 until Rule M7. Note 2: Abstract multiple primaries when you have any of the following combinations (all coded 8311): • MiT family translocation renal cell carcinoma and Hereditary leiomyomatosis • MiT family translocation renal cell carcinoma and Renal cell carcinoma-associated renal cell carcinoma • MiT family translocation renal cell carcinoma and Succinate dehydrogenase-deficient renal cell carcinoma (SDHS) • Hereditary leiomyomatosis and Succinate dehydrogenase-deficient renal cell carcinoma (SDHS) • Renal cell carcinoma-associated renal cell carcinoma and Succinate dehydrogenase-deficient renal cell carcinoma (SDHS)
Malignant CNS Table 3: 9540 row: Added as a subtype/variant: "Epithelioid malignant peripheral nerve sheath tumor 9542"
https://seer.cancer.gov/tools/solidtumor/revisions.html